Healthcare · Diagnostics & Research
Dr. Lal Path Labs Ltd.
LALPATHLAB
Financials as of(≥90-day lag, SEBI compliant)
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
NSE: LALPATHLABOfficial website ↗
Key metrics
Market Cap
₹23,455 cr
P/E Ratio
44.44x
P/B Ratio
10.8x
ROE
22.42%
ROCE
27.77%
Debt / Equity
0.07x
Net Margin
19.79%
Dividend Yield
93%
EPS
₹29.2
Period
FY2025
Shareholding pattern
As of LatestPromoter: 54.91%FII: 31.55%Public: 13.54%
Deep-dive pages
Educational content — not investment adviceThis page presents publicly available information about Dr. Lal Path Labs Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.